Suchen Sie nach Informationen zu Ortho Mcneil Janssen Pharmaceuticals Corporate Officers? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.northernsteelvic.com.au/o-corporate-office/ortho-mcneil-janssen-pharmaceuticals-corporate-officers.html
McNeil Pharmaceuticals, Ortho Pharmaceuticals Corporation Ownership Status Acquired/Merged Financing Status Formerly VC-backed Primary Industry Pharmaceuticals Other Industries Drug Discovery Acquirer Janssen Global Services Primary Office 1000 U.S. Route 202 South Raritan, NJ 08869 United States +1 (800) 000-0000
https://opencorporates.com/companies/us_ky/0728527
Free and open company data on Kentucky (US) company ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. (company number 0728527) [Webinar] Fighting Financial Crime: The White Box Company Data Revolution – listen to the recording. ... Branch of Pennsylvania (US) company Inactive Directors / Officers. C T CORPORATION SYSTEM, agent; Registry Page https ...
https://www.bloomberg.com/profile/company/89784Z:US
Ortho-McNeil Pharmaceutical LLC. Janssen Pharmaceuticals, Inc was founded in 1940. The company's line of business includes the manufacturing of bulk …
https://en.wikipedia.org/wiki/Ortho-McNeil-Janssen
https://opencorporates.com/companies/us_ca/200927510150
Company Type FOREIGN Jurisdiction California (US) Branch Branch of ORTHO-MCNEIL PHARMACEUTICAL, LLC (Delaware (US)) Registered Address. 1001 US HWY RTE 202 N RARITAN NJ 08869; United States; Inactive Directors / Officers. C T CORPORATION SYSTEM, agent; JANSSEN PHARMACEUTICALS INC; Registry Page https://businesssearch.sos.ca.gov/CBS...
https://pitchbook.com/profiles/company/51223-78
0000000000. 0. US-7179604-B2. Cloning the dna and expressing the receptor; monospecific antibody reactive with the receptor protein; identifying receptor modulators; treating conditions mediated by a human histamine h3 receptor. Expired - Lifetime. 07-Oct-1998. C07K14/723. 00. To view Ortho-McNeil Pharmaceuticals’s complete patent history ...
https://johnsonandjohnson.gcs-web.com/news-releases/news-release-details/ortho-mcneil-janssen-pharmaceuticals-inc-resolves-investigation
Titusville, NJ (April 29, 2010) - Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) today announced an agreement with the U.S. Attorney's Office for the District of Massachusetts, the U.S. Department of Justice, and other federal agencies to resolve a previously reported government investigation of past U.S. marketing and promotional practices for …
https://www.prnewswire.com/news-releases/ortho-mcneil-janssen-pharmaceuticals-inc-resolves-investigation-of-past-topamaxr-marketing-and-promotional-activities-92425439.html
Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been cooperating with the government since its investigation began in December 2003. OMJPI has entered into a settlement agreement resolving the ...
https://policymed.typepad.com/files/orhtomcneil-cia-4-29-10.pdf
CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND ORTHO-McNEIL-JANSSEN PHARMACEUTICALS, INC. I. PREAMBLE Ortho-McNeil-Janssen Phannaceuticals, Inc. (OMJPI) hereby enters into this Corporate Integrity Agreement (CIA) with the Office ofInspector General …
Visit Janssen CarePath to learn how we’re continuing to help patients in the U.S. afford and access our medicines. Backed by the size and reach of Johnson & Johnson, we are transforming lives and reinventing healthcare as we tackle society's most pressing health challenges.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Ortho Mcneil Janssen Pharmaceuticals Corporate Officers gefunden haben.
